The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
about
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseCleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosisCaspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosisTTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activationT6BP, a TRAF6-interacting protein involved in IL-1 signalingFIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activationInterchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signalingSMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition.Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspasesFrom death receptor to reactive oxygen species and c-Jun N-terminal protein kinase: the receptor-interacting protein 1 odysseyXIAP: cell death regulation meets copper homeostasisA novel role for XIAP in copper homeostasis through regulation of MURR1VIAF, a conserved inhibitor of apoptosis (IAP)-interacting factor that modulates caspase activationRIP2 is a novel NF-kappaB-activating and cell death-inducing kinaseAnatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteinsI-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transductionTRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activationIdentification of an antiapoptotic protein complex at death receptorsA novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaThe USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complexOTUB1 modulates c-IAP1 stability to regulate signalling pathwayscIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4)Coactivator TIF1beta interacts with transcription factor C/EBPbeta and glucocorticoid receptor to induce alpha1-acid glycoprotein gene expression.Molecular determinants of NF-kappaB-inducing kinase actionTNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitinationThe c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspasesIAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspasesp53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1.XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathwayHuman IAP-like protein regulates programmed cell death downstream of Bcl-xL and cytochrome cEtk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesisInhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs.Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein familyTANK potentiates tumor necrosis factor receptor-associated factor-mediated c-Jun N-terminal kinase/stress-activated protein kinase activation through the germinal center kinase pathwayLymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaBIs NF-kappaB a good target for cancer therapy? Hopes and pitfallsTumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming proteinCD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival
P2860
Q21093232-677FAEE8-7F2B-4389-ACB5-75F7B9E14C8EQ22010649-1F8DEAA9-0C34-443C-ABB1-220941083920Q22253249-E74D2074-93AA-4709-938C-018F76A8B664Q22253885-A83AEE2D-CDFE-4330-A790-DD6A988D4DAFQ22254711-45A8B7FD-0310-452E-A466-851A4D3C3FC5Q24290412-8B9DE71B-4A60-4162-BE77-729ABCB7711FQ24291474-34529815-536C-4D6F-8026-A380B4E1AFF8Q24292189-BD3EEC75-4677-412A-8DB5-98937D5CFC85Q24292370-F7C853BC-880F-4960-A26B-5A8C4306B9B6Q24294565-8DB3592B-F1F7-4D93-BBD6-28263F4A55B9Q24299330-191A8A59-776D-48D0-BF2E-D79DC8F56005Q24300814-2FE8D371-EBAE-4B23-9175-5100492AE34EQ24302274-9E760A6E-0E12-493D-BA54-FED3282EE3A5Q24304221-4367FD6B-A00B-4D30-8FEB-842C7C276CFFQ24310179-567E2AE6-3EF6-4DBA-8CC6-FBC44057D4D6Q24311703-15BABE09-8C41-4C9D-BE89-6CB7FDE5FC23Q24313173-5E36F80F-D63B-42A0-811A-F4A1F71766FFQ24313308-669BFC29-27F7-43C3-9BD9-6344F6B2E096Q24321594-5281B767-4021-4E80-A35E-0DE066CE8061Q24322614-B27BD6A2-1DB0-4458-A069-252BBFE4D4EBQ24323126-A5D8F9F8-D7AE-4E2A-8684-4D71F1F162D8Q24323338-84CAE7C5-AA1E-4AC8-92C0-1A003E73A19AQ24337266-478DA84C-DBB3-4DF8-9740-3C9E4C6EE2E8Q24338276-AA6BE71E-BBF7-4B3A-8400-548AA0B26848Q24522749-58EC6EE5-CC2C-4F5A-9565-5A75B28B5BA9Q24522758-6B7A5B46-9463-43F9-8A35-F91550CC41BFQ24529129-372E4FC4-CE00-460C-B944-60DD3F6636CEQ24532851-57837104-403E-4679-9C6E-3D733AB9D065Q24533214-80F6417B-70BD-4E7A-8217-177187794E4FQ24533238-D21A7D1C-B398-4A11-A16A-EB32366BA7ABQ24533501-B31A822F-6ED5-4D02-8B1D-0A9E156D2E4AQ24533921-3F656EF1-4998-40D4-8E51-3CBAFE944718Q24540207-7BF0A1EF-5347-4F9E-8481-D3A85BD65F09Q24544173-48311B72-D4D0-45CB-9A03-643E3A26847AQ24550944-B1593C92-9BD1-45AC-B054-F67CBB84D564Q24554425-153E7080-1C03-40E2-AC2A-5238E1B0BB18Q24564927-4FFDEB6C-1CDC-4AA9-B232-99148B192629Q24570128-1C38E339-1099-4987-9B49-9BC979F188D9Q24599252-911FDCAB-9FB9-4987-AD93-8539D45913B1Q24605401-D9615866-7E29-44EA-99D9-2552F63F2ECB
P2860
The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
description
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1995
@ast
im Dezember 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/12/29)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/12/29)
@nl
наукова стаття, опублікована в грудні 1995
@uk
научни чланак (објављен 1995/12/29)
@sr
name
The TNFR2-TRAF signaling compl ...... nhibitor of apoptosis proteins
@ast
The TNFR2-TRAF signaling compl ...... nhibitor of apoptosis proteins
@en
The TNFR2-TRAF signaling compl ...... nhibitor of apoptosis proteins
@nl
type
label
The TNFR2-TRAF signaling compl ...... nhibitor of apoptosis proteins
@ast
The TNFR2-TRAF signaling compl ...... nhibitor of apoptosis proteins
@en
The TNFR2-TRAF signaling compl ...... nhibitor of apoptosis proteins
@nl
prefLabel
The TNFR2-TRAF signaling compl ...... nhibitor of apoptosis proteins
@ast
The TNFR2-TRAF signaling compl ...... nhibitor of apoptosis proteins
@en
The TNFR2-TRAF signaling compl ...... nhibitor of apoptosis proteins
@nl
P2093
P921
P3181
P1433
P1476
The TNFR2-TRAF signaling compl ...... nhibitor of apoptosis proteins
@en
P2093
P304
P3181
P356
10.1016/0092-8674(95)90149-3
P407
P577
1995-12-01T00:00:00Z